Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery
- 1 December 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Coronary Artery Disease
- Vol. 19 (8), 619-625
- https://doi.org/10.1097/mca.0b013e3283142607
Abstract
In an observational study, we evaluated the association between postoperative statin therapy and long-term mortality among patients undergoing a first-ever coronary artery bypass grafting (CABG) surgery. In an outpatient clinic setting, we assessed 1869 consecutive patients (age 58.7+/-9.6 years; 1657 men), who survived the 1st month after a first-ever CABG, within a 17-year period. Cox proportional hazard analysis was used to calculate the adjusted hazard ratios (adjusting for age, smoking, the presence of hypertension, diabetes mellitus, lipid profile at the time of the procedure, vessel disease, number and kind of grafts used, and concomitant treatment) for patients receiving statin treatment during follow-up and adjusted Kaplan-Meier survival curves were constructed. During a 9345 patient-years follow-up, 48% of the patients were on a statin. In a total of 222 deaths, 80.6% were because of cardiovascular causes. Total and cardiovascular mortality were significantly reduced in patients receiving statin therapy [adjusted hazard ratio, 0.48 (95% confidence interval, 0.28-0.82); P=0.007), and 0.43 (95% confidence interval, 0.23-0.80); P=0.007, respectively]. The estimated 16-year Kaplan-Meier survival curves diverged at 2 years and thereafter. Taking into account the potential limitations of observational data, statin treatment postoperatively is associated with a 50% reduction in total and cardiovascular mortality in patients undergoing a first-ever CABG.Keywords
This publication has 20 references indexed in Scilit:
- Smoking cessation is associated with reduced long-term mortality and the need for repeat interventions after coronary artery bypass graftingEuropean Journal of Preventive Cardiology, 2007
- Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery DiseaseThe Annals of Thoracic Surgery, 2007
- Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Occurrence and Risk Factors for Reintervention After Coronary Artery Bypass GraftingCirculation, 2006
- Statins Are Associated With a Reduced Incidence of Perioperative Mortality After Coronary Artery Bypass Graft SurgeryCirculation, 2004
- Role of statin therapy in the coronary bypass patientThe Annals of Thoracic Surgery, 2004
- Incidence and other epidemiological characteristics of sudden cardiac death in northwest GreeceInternational Journal of Cardiology, 1995
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists CollaborationThe Lancet, 1994
- Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-upJournal of the American College of Cardiology, 1992
- The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native CirculationThe New England Journal of Medicine, 1984